Knowledge about human papillomavirus and the HPV vaccine – a survey of the general population
| Autor: | Erin A. Jones, Aletha Y. Akers, Kourtney L. Hagan, Camille Ragin, Susanne M. Gollin, Cierra M. Moss, Cornelius Bondzi, Dwight E. Heron, Ar’Lena C. Smith, Emanuela Taioli, Robert P. Edwards, Cecile Andraos-Selim, Jade Jones, Linda Robertson, Natalie Thurman |
|---|---|
| Jazyk: | angličtina |
| Předmět: |
Cancer Research
Pathology medicine.medical_specialty Epidemiology Population Ethnic group Genital warts 03 medical and health sciences 0302 clinical medicine medicine 030212 general & internal medicine education Cervical cancer education.field_of_study business.industry Incidence (epidemiology) virus diseases Vaccine efficacy medicine.disease female genital diseases and pregnancy complications 3. Good health Proceedings Infectious Diseases Oncology 030220 oncology & carcinogenesis Tropical medicine Population study business Demography |
| Zdroj: | Infectious Agents and Cancer |
| ISSN: | 1750-9378 |
| DOI: | 10.1186/1750-9378-4-s1-s10 |
| Popis: | Background The United States (US) Food & Drug Administration (FDA) recently approved a human papillomavirus (HPV) vaccine with the purpose of reducing the risk of cervical cancers caused by HPV 16 and HPV 18. It is important that the general population be educated about HPV and the HPV vaccine in order to make the appropriate decision whether or not to vaccinate against this virus. Participants from the adult US general population of Pittsburgh, Pennsylvania, USA and Hampton, Virginia, USA (18+ years old) were surveyed to determine their knowledge about HPV and the HPV vaccine, and to evaluate their perception of the vaccine efficacy and safety. Results We report herein preliminary data for 202 participants. Fifty-five percent (55%) of the study population was White, 45% Black, and 1% was from other ethnic groups or did not disclose their ethnicity. A large proportion of participants had heard of the human papillomavirus (overall population: 93.6%; Pittsburgh: 95%; Hampton: 90%). Participants of African descent were slightly less aware of HPV than Whites (Black 89% vs. Whites 97%, p > 0.1). Although the majority of participants knew that HPV caused cervical cancer (84%), Whites were more informed than Black participants (91% vs. 73%, p = 0.044). Eighty-seven percent (87%) of participants had heard of the HPV vaccine (Pittsburgh: 92% and Hampton: 74%, p = 0.029); a higher proportion of Whites were aware of the vaccine when compared with Blacks (93% vs. 76%, p = 0.031). However, only 18% of the population knew that the current FDA-approved vaccine protected against genital warts and most cervical cancer (20% of Blacks and 16% of Whites, p > 0.1). Conclusion These data suggest that although the general population might be aware of HPV and the HPV vaccine, knowledge of the benefits of the HPV vaccination may not be apparent. Knowledge of HPV and the HPV vaccine could result in a likely choice of HPV vaccination and would subsequently reduce the incidence of cervical cancer. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|